Position in JNJ
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,881,917
+$144,438 QoQ
Shares Held
7,410
+4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,404
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mirador Capital Partners LP holds $28,463,151 across 9 Drug Manufacturers - General names. JNJ ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,762 | $17,303,269 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
48,795 | $2,811,567 | |
| 3 | LLY |
ELI LILLY & Co
|
1,657 | $1,987,455 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
7,410 | $1,881,917 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,099 | $1,781,267 | |
| 6 | PFE |
Pfizer Inc
|
45,835 | $1,103,706 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,882 | $755,837 | |
| 8 | AMGN |
Amgen Inc
|
1,410 | $510,589 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,881,917 | 7,410 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $1,737,479 | 7,108 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,423,609 | 6,879 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,121,049 | 6,046 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $741,295 | 4,853 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $763,693 | 4,605 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $677,110 | 4,682 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $719,060 | 4,437 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $660,350 | 4,518 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $3,244,160 | 20,508 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,083,859 | 19,675 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $3,139,764 | 20,159 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $3,809,939 | 23,018 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,607,935 | 23,277 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $1,706,262 | 9,659 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,531,990 | 9,378 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,650,665 | 9,299 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,503,796 | 8,485 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,361,203 | 7,957 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,262,122 | 7,815 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,285,301 | 7,802 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,520,237 | 9,250 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,306,096 | 8,299 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,227,962 | 8,248 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,074,835 | 7,643 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $974,033 | 7,428 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||